Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 2015;385(9971):875-82. https://www.ncbi.nlm.nih.gov/pubmed/25468170
Chen JA, Lin HC, Wei HM, Hsu YL, Lai HC, Low YY, et al. Clinical characteristics and outcomes of culture-negative versus culture-positive osteomyelitis in children treated at a tertiary hospital in central Taiwan. J Microbiol Immunol Infect 2021;54(6):1061-9. https://www.ncbi.nlm.nih.gov/pubmed/32891539
Fantoni M, Taccari F, Giovannenze F. Systemic antibiotic treatment of chronic osteomyelitis in adults. Eur Rev Med Pharmacol Sci 2019;23(2 Suppl):258-70. https://www.ncbi.nlm.nih.gov/pubmed/30977893
Gariani K, Pham TT, Kressmann B, Jornayvaz FR, Gastaldi G, Stafylakis D, et al. Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomized, Noninferiority Pilot Trial. Clin Infect Dis 2021;73(7):e1539-e45. https://www.ncbi.nlm.nih.gov/pubmed/33242083
Gigante A, Coppa V, Marinelli M, Giampaolini N, Falcioni D, Specchia N. Acute osteomyelitis and septic arthritis in children: a systematic review of systematic reviews. Eur Rev Med Pharmacol Sci 2019;23(2 Suppl):145-58. https://www.ncbi.nlm.nih.gov/pubmed/30977881
Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med 2019;380(5):425-36. https://www.ncbi.nlm.nih.gov/pubmed/30699315
McMullan BJ, Andresen D, Blyth CC, Avent ML, Bowen AC, Britton PN, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis 2016;16(8):e139-52. https://www.ncbi.nlm.nih.gov/pubmed/27321363
Park KH, Cho OH, Jung M, Suk KS, Lee JH, Park JS, et al. Clinical characteristics and outcomes of hematogenous vertebral osteomyelitis caused by gram-negative bacteria. J Infect 2014;69(1):42-50. https://www.ncbi.nlm.nih.gov/pubmed/24561018
Park KH, Chong YP, Kim SH, Lee SO, Choi SH, Lee MS, et al. Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus. J Infect 2013;67(6):556-64. https://www.ncbi.nlm.nih.gov/pubmed/23916563
Wong D, Holtom P, Spellberg B. Osteomyelitis Complicating Sacral Pressure Ulcers: Whether or Not to Treat With Antibiotic Therapy. Clin Infect Dis 2019;68(2):338-42. https://www.ncbi.nlm.nih.gov/pubmed/29986022
